Grammy® Nominated Songwriter and Singer Turns His ‘Pain

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Grammy® Nominated Songwriter and Singer Turns His ‘Pain Into Purpose’

NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- On January 5 th , 2016, Grammy nominated songwriter and singer Tracy Randall , as he battles stage 4 cancer, will release, “Be Free,”  the first single off of his third studio album, " No Judgment,"  to impact radio . But, the Lavish Records recording artist Tracy Randall isn’t supposed to be here. In 2006, he was diagnosed with acute lymphocytic leukemia, underwent aggressive rounds of chemo and radiation therapy, and his doctors gave up.

Photos accompanying this announcement are available at:

http://www.globenewswire.com/NewsRoom/Attachm...c0693f6a83

http://www.globenewswire.com/NewsRoom/Attachm...385560caf3

In February 2007 doctors told him to go home and prepare to die; he had between three to six months to live. “However, the 6 months turned to 6 years,” he recalls. He left the office that cold, rainy afternoon and started walking. “I began to pray and talk to God, not about me, but about my family and their survival because I’m the breadwinner.” As he walked past the 42 nd Street subway, where he usually caught the train, he kept walking, talking. “By the time I got to 96 th Street this voice said, 'You’re going to be okay.'” His testimony on YouTube has over 300,000 views. Unfortunately, after being in remission for almost seven years, the cancer came back with a vengeance, trying to stop his praise and love for Christ.

“Be Free” displays Randall’ s heart as he sings this definite acknowledgement and highest praise to our Lord and Savior Jesus Christ.  “Be Free” a soulful and heartfelt song that emotes his plea to Christ not to heal his body but to give him the courage and strength to endure the depression that he is being attacked with along with cancer. “Early morning pain keeps me in the bed, I can barely move, Voices telling me I should be dead, I focus on you,” he sings on this almost soulful huge pop ballad. "Part of me gave up, Part of me stood strong. I know I can do this. In my mind there’s doubt. Asking myself how.  How will I get through this?”                                        “I want to be free (free). From this hurt and pain. This hurt and pain. This hurt and pain.” The song is the first single from Randall’s third CD “No Judgment” releasing on March 25 th , 2016 that features tracks of what he calls Rhythm & Gospel. “It’s gospel music,” Randall explains. “But it has that urban R&B beat.”  It is quite clear that Randall is going to be a mainstay in Christian music for he has impacted pop radio with his inspiring first single of his sophomore album, “I Am All You Need” peaking at #36 on the Billboard Top 40 and the second single entitled “It Feels Good” remained in the top 100 for over 8 weeks on the Gospel Billboard Charts.

Randall , the Lake Charles and LA native grew up on a musical diet of Donny Hathaway and Stevie Wonder. After completing his undergraduate degree from LeMoyne-Owen College in Memphis, Randall was signed to the Isley Brothers’ T-Neck/Island Records label. After Universal/Polygram took over the company in 1999, he left to start Lavish Records. He released his first gospel CD “Sinners Have Souls Too” in 2007 and has done a lot of behind the scenes work in the music industry. Randall co-wrote four songs on Shaggy’s Grammy Award nominated “Summer in Kingston” CD that reached #1 on Billboard’s Top Reggae Albums chart in 2012. Click to listen to “Be Free” . 

For more information contact Kimberly Johnson

Media/Press Contact: Kimberly Johnson KIMJOHNSON@RANDALLSLAWFIRMPC.COM 1.888.445.8708 ext. 1

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 21

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 14

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 510

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 7

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 370

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
AI Agents Redefine Finance: Deutsche & Ant Tech

Updated Category News Views 16

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

First Savings Financial Group Shares Exciting Dividend News

Updated Category News Views 159

First Savings Financial Group, Inc. Declares Special Cash Dividend In a recent announcement, First Savings Financial Group, Inc. (NASDAQ: FSFG), a prominent holding company, revealed that their Board of Directors has approved a quarterly cash dividend of $0.16 per common share. This generous dividend is a reflection of the company’s positive financial health and...

Continue Reading
Ransomware Attacks Surge: Insights from Coalition's Findings

Updated Category News Views 222

Ransomware Attacks Surge: Insights from Coalition's Findings SAN FRANCISCO-- Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, has published its latest findings revealing a significant turnaround in the landscape of cyber threats. Recent statistics show that ransomware claims severity has increased by 68%, reaching...

Continue Reading
Metropolitan Commercial Bank's ACH Cloud Shift: Game Changer or Risky Play?

Updated Category News Views 250

On February 17, 2026, Metropolitan Commercial Bank (MCB) completed a major transition by fully retiring its legacy ACH mainframe and moving to Finzly’s cloud-native payment platform. This move positions MCB as a pioneer among U. S. banks as the industry grapples with modernizing aging systems—a reality that has been highlighted by looming regulatory changes. You know...

Continue Reading
GEODIS Names Laura Ritchey President & CEO of Americas Region

Updated Category News Views 401

GEODIS Appoints New President and CEO for the Americas GEODIS, a prominent figure in the logistics and transportation industry, has announced the appointment of Laura Ritchey to the position of President & CEO of its Americas region. In this crucial role, Ritchey will be part of the Group's Executive Board and will report to Marie-Christine Lombard, the Group's Chief...

Continue Reading
Conagra Brands Set to Share Fiscal 2026 Q2 Earnings Announcement

Updated Category News Views 341

Conagra Brands Announces Earnings Release Date Conagra Brands, Inc. (NYSE: CAG) recently made a significant announcement regarding its fiscal 2026 second quarter results. The much-anticipated earnings release is scheduled for a Friday, marking an important milestone for the company and its stakeholders. Details of the Earnings Call The earnings call will take place on a...

Continue Reading